Status
Conditions
Treatments
About
Aim of the study is assessment the prevalence of the low ankle-brachial index (ABI) defined less than or equal 0.9 in patients with acute cerebral ischemic event (stroke or transient ischemic attack) and determinate the correlation between ABI and internal carotid artery stenosis (ICAS) in the acute cerebral ischemic patients.
The low ABI is a strong marker of generalized atherosclerosis. LEAD is a strong independent predictor for stroke.
Full description
Aim of the study is assessment the prevalence of the low ankle-brachial index (ABI) defined less than or equal 0.9 in patients with acute cerebral ischemic event (stroke or transient ischemic attack) and determinate the correlation between ABI and internal carotid artery stenosis (ICAS) in the acute cerebral ischemic patients.
The ABI is a non-invasive tool useful for the diagnosis of LEAD. The low ABI is a strong marker of generalized atherosclerosis. LEAD is a strong independent predictor for stroke. Significant ICAS is prevalent among patients having LEAD. Acute ischemic stroke due to significant ICAS has poor prognosis.
Patients with LEAD may be a suitable subgroup for screening for ICAS using duplex scanning.
Estimating the relationship between cerebral ischemic event and the ABI value could help better guide preventive and risk reduction strategies.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
200 participants in 2 patient groups
Loading...
Central trial contact
Paweł Sokal, Ph.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal